One-pot bio-synthesis: N-acetyl-d-neuraminic acid production by a powerful engineered whole-cell catalyst by Tao, Fei et al.
One-pot bio-synthesis:
N-acetyl-D-neuraminic acid production
by a powerful engineered whole-cell
catalyst
Fei Tao
1,2*, Yinan Zhang
2*, Cuiqing Ma
2 & Ping Xu
1
1State Key Laboratory of Microbial Metabolism, Shanghai Jiao Tong University, Shanghai 200240, People’s Republic of China,
2State Key Laboratory of Microbial Technology, Shandong University, Jinan 250100, People’s Republic of China.
Whole cell biocatalysis is an important tool for pharmaceutical intermediates synthesis, although it is
hinderedbysomeshortcomings,suchashighcostandtoxicityofinducer,masstransferresistancecausedby
cell membrane and side reactions. Whole-cell catalysis using N-acetyl-D-glucosamine 2-epimerase (EC
5.1.3.8) and N-acetyl-D-neuraminic acid (Neu5Ac) aldolase (EC 4.1.3.3) is a promising approach for the
productionofNeu5Ac,apotentialprecursorofmanyanti-viraldrugs.Apowerfulcatalystwasdevelopedby
packaging the enzymes in an engineered bacterium and using a safe temperature-induced vector. Since the
mass transfer resistance and the side reactions were substantially reduced, a high Neu5Ac amount
(191 mM)wasachieved.Anefficientmethodwasalsopresented,whichallowsone-potsynthesisofNeu5Ac
with a safe and economic manner. The results highlight the promise of large-scale Neu5Ac synthesis and
point at a potential of our approach as a general strategy to improve whole-cell biocatalysis.
I
n light of the current pandemic threat and the emergence of oseltamivir resistance, development of effective
anti-influenza drugs and related precursors is crucial
1,2. N-Acetyl-D-neuraminic acid (Neu5Ac) and its deri-
vativesplaysignificantrolesinmanyphysiologicalandpathologicalprocesses,suchascellularrecognitionand
communication, bacterial and viral infections, and tumour metastasis
3–5. Therefore they are potentially useful
pharmaceutical molecules. For example, zanamivir (Neu5Ac2en, 2-deoxy Neu5Ac, Biota/Glaxo), a commercial
derivativeofNeu5Ac,hasbeenusedtoinhibittheneuraminidasesofinfluenzavirusesAandBinclinicalsettings.
This compound prevents influenza virus infections, such as those caused by the avian influenza virus H5N1 and
the current H1N1
1,6,7. However, the high price of Neu5Ac caused by its conventional method of production has
impeded its industrial application.
Neu5Ac can be prepared from natural sources by hydrolysis
8, enzymatic conversion
9–12, or chemical syn-
thesis
13,14. Among these methods, enzymatic conversion catalyzed by N-acetyl-D-glucosamine (GlcNAc)
2-epimerase (EC 5.1.3.8) and Neu5Ac aldolase (EC 4.1.3.3) is preferred
9–12,15, because of the high efficiency of
the process and cheap substrates used (pyruvate and GlcNAc)
16,17. However, the enzymes must be partially or
completely purified, and ATP is required to activate GlcNAc 2-epimerase; consequently the process is compli-
catedandcostly.Incomparisonwithisolatedenzymes,whole-cellcatalystscanbemorereadilyandinexpensively
prepared and are particularly useful for multi-enzyme reactions or those that require cofactor regeneration
18–20.
Neu5Acproductionusingcoupledwhole-cellcatalystshasbeenreported,buttheproductamountandreaction
rate are much lower than enzymatic catalysis
21–24. This disadvantage of coupled whole-cell catalysts is largely due
tothemasstransferresistancecausedbycellmembrane,whichalsoexistsinotherpreviouslyreportedwhole-cell
catalyses and has hindered their industrial applications
19. It is notable that the reactions catalyzed by GlcNAc
2-epimeraseandNeu5Acaldolasewereseparatelypackagedintwotypesofcellsinallthepreviousreports,where
the reaction intermediate (N-acetyl-D-mannosamine, ManNAc) needs to penetrate between cells
21–24. Therefore,
singlecellpackagingofthereactionswouldpreventthepenetrationofManNAcandthenlargelyreducethemass
transfer resistance. Moreover, packaging the reactions in a single cell would also simplify the operation.
The existence of side reactions is another factor leading to low efficiency of whole-cell catalyzed Neu5Ac
production. Because living cells still have certain metabolic capabilities, the side reactions that occur during the
whole-cellcatalyticprocessesaregenerallymoreseriousthanthoseoccurduringenzymaticsynthesis
19.Themore
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cell biocatalysis which may seriously hamper product purification
and reduce the overall yield
19,25. In whole-cell catalyzed synthesis of
Neu5Ac,boththesubstrates pyruvate andGlcNAccanbeutilized by
the cells, where pyruvate is the central branch point and GlcNAc
serves as the carbon and nitrogen source
26. Of the two substrates
required for Neu5Ac synthesis, GlcNAc is relatively more expensive
and is mainly transported into cells by the active transporter of the
phosphotransferase system (PTS) with phosphorylation followed by
mineralization
26. Therefore, the elimination of PTS for GlcNAc
should be effective in reducing the GlcNAc-related side reactions
and the cost.
Chemical induction systems such as isopropyl b-D-1-thiogalacto-
pyranoside (IPTG) induced system are frequently used for driving
gene expression
27. However, for applications such as development of
organisms for use in food products and development of biocatalysts
for therapeutic products, supplement of the toxic and expensive
inducer for induction is undesirable
27,28. Temperature induction is
considered as a good alternative of chemical induction for scaled-up
production of therapeutic products using biocatalysis because of its
safety, low cost, and ease of operation
27,28. Therefore, developing a
biocatalystbasedontemperatureinductionexpressionsystemwould
be beneficial to the industrialization of whole-cell catalyzed Neu5Ac
production. Actually, a temperature induction vector named
pBV220 has been successfully used in Neu5Ac production by
coupled whole cells in our previous work
24.
With these considerations in mind, we constructed a whole-cell
catalyst by genetic engineering. At first, a mutant of Escherichia coli
K12 was constructed by elimination of the PTS for GlcNAc. Then,
the two reactions catalyzed by GlcNAc 2-epimerase and Neu5Ac
aldolase were packaged in the single cell of the mutant by co-expres-
sing the slr1975 gene from Synechocystis sp. PCC6803 and the nanA
gene from E. coli K12. A novel one-pot reaction method for Neu5Ac
production was also developed with the catalyst (Fig. 1). A series of
whole-cell reactions were performed to investigate the advantages of
the constructed catalyst and developed method.
Results
Construction of E. coli DT26/pBVNsS. To coexpress the slr1975
gene encoding GlcNAc 2-epimerase and the nanA gene encoding
Neu5Ac aldolase in the same cell, pBVNsS was constructed using a
temperature-induced expression vector pBV220 as described in the
method(Fig.2A,Fig.S1).Theconstructionwas verifiedbyrestriction
digest. To determine whether genes slr1975 and nanA could be co-
expressed in E. coli cells, the constructed plasmid pBVNsS was intro-
duced into E. coli K12 to form E. coli K12/pBVNsS. E. coli K12/
pBVNsS was then cultured in lysogenic broth (LB) and induced at
42uC, followed by SDS-PAGE analysis (Fig. 2B). As controls, strains
E. coli K12/pBV220 (E. coli K12 harbouring plasmid pBV220), E. coli
K12/pBVN
24,a n dE.coli K12/pBVS
24wereused.Figure 2Bshows that
the two proteins were coexpressed in the recombinant strain, which
indicated that the construction of pBVNsS was successful.
To eliminate the catabolism of GlcNAc, the nagE gene was dis-
ruptedusing homologous recombination asdescribed in themethod
(Fig.2C,Fig.S2).PCRwasusedtoverifythedisruptioneventofnagE
gene using primer set PnagE-u plus PnagE-d. The result in Fig. 2D
shows that the PCR using the primer set generated products of the
expected sizes. The resulting mutant was named DT26. The desired
strain E. coli DT26/pBVNsS was then constructed by transforming
E. coli DT26 with pBVNsS (Fig. 1).
Reaction catalyzed by E. coli DT26/pBVNsS. To demonstrate the
advantages of E. coli DT26/pBVNsS, various reaction solutions were
prepared for Neu5Ac production (reaction A, E.coli DT26/pBVNsS;
reaction B, E. coli K12/pBVNsS; and reaction C, E. coli K12/pBVN
and E. coli K12/pBVS). Using 1 M pyruvate and 200 mM GlcNAc,
Neu5Ac wasformed. NoATPwasaddedinanyof thereactions. The
Neu5Ac amount, average reaction rates, and yields were compared
(Table 3). After induction, the enzyme activities of the different
induced whole cells were also calculated and listed (Table 3). It was
showed that E. coli DT26/pBVNsS produced 59.8 mM Neu5Ac in
48 h while E. coli K12/pBVNsS and the coupled whole cells (E. coli
K12/pBVN and E. coli K12/pBVS) produced 36.8 and 25.1 mM
Neu5Ac, respectively.
Time courses of Neu5Ac production in the three reaction solu-
tions were also investigated and described in Fig. 3. Figure 3
shows that the reaction rate of reaction A (1.4 mmol l
21 h
21)i s
much higher than that of reaction of B (1.0 mmol l
21 h
21) and C
(1.0 mmol l
21h
21). It is also showed that the time of reactions A and
B (24 h) is longer than that of reaction C (42 h) when the concen-
tration of Neu5Ac increased. In reaction C, it appears as if Neu5Ac
productionisbiphasic,withanearlyrapidrateandalaterslowerrate,
which is consistent with our previous report
24. However, this phe-
nomenon cannot be observed in reactions A and B.
Figure 1 | One-pot bio-synthesis scheme of Neu5Ac production by the constructed whole-cell catalyst. The rounded rectangle indicates a cell of the
engineered E. coli DT26, whose GlcNAc-specific PTS was eliminated to reduce side reactions about GlcNAc. The enzymes GlcNAc 2-epimerase (I) and
Neu5Ac aldolase (II) were coexpressed in E. coli DT26 with a safe temperature-induced vector. The mass transfer resistance was mainly caused by the
membrane permeation of substrate and product (the membrane penetration by the intermediate ManNAc does not exist). : Membrane affected by
cetyltrimethylammonium bromide (CTAB) that was used to reduce the mass transfer resistance caused by membrane. : The indicated function,
GlcNAc-specific PTS (III), was eliminated, which would reduce side reactions about GlcNAc. ATP (adenosine triphosphate) was supplied by the cell.
www.nature.com/scientificreports
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disruptionofnagE,1 MGlcNAc(almostthesaturatedconcentration)
was used in Neu5Ac production reactions. Figure 4 shows the time
courses of Neu5Ac production by different types of reactions. E. coli
DT26/pBVNsS synthesized 86.8 mM Neu5Ac in 60 h while E. coli
K12/pBVNsS produced 38.0 mM Neu5Ac and coupled cells
(E.coli K12/pBVN 1 E. coli K12/pBVS) produced 21.3 mMNeu5Ac.
Effect of surfactant on Neu5Ac production. To enhance the mass
transfer of substrates and product, different surfactants were supple-
mented in Neu5Ac production reaction solutions, respectively. The
result showed that the surfactant cetyltrimethylammonium bromide
(CTAB) has the best effect on improving Neu5Ac production
(Fig.S5).Timecourses ofNeu5Ac producing reactionswith/without
CTAB are showed in Fig. 5. It is showed that strain E. coli DT26/
pBVNsS could produce 191.9 mM Neu5Ac in reaction mixture
containing CTAB, while only 75.2 mM Neu5Ac was synthesized in
mixture without CTAB.
Figure 2 | Construction of E. coli DT26/pBVNsS. (A) Map of pBVNsS. PLPR, promoters; MCS, multiple cloning site; rrnBT1T2, transcriptional
terminator; Amp
r, ampicillin resistance gene; ori, origin of plasmid replication; cIts857, temperature sensitive gene. (B) SDS-PAGE analysis of cells after
heat induction. Lane 220: E. coli K12/pBV220 bacterial protein; Lane N: E. coli K12/pBVN bacterial protein; Lane S: E. coli K12/pBVS bacterial protein;
Lane NS: E. coli K12/pBVNsS bacterial protein; Lane M: molecular mass standard. (C) diagram illustrating the sequence analysis of the disruption of the
nagE. (D) Analysis of PCR fragments to confirm nagE disruption. Lane M: molecular mass standard (l DNA/HindIII); Lane 1-4: product amplified
with mutant genomic DNA as the template; Lane 5: product amplified with wild-type E. coli genomic DNA as the template. The PCRs were performed
with primers PnagE-u and PnagE-d.
Figure 3 | Time courses of Neu5Ac production in the three reaction
solutions. m,reactionA;&,reactionB;$,reactionC.Errorbarsindicate
s.d. (n53).
Figure 4 | Comparison of the reactions catalyzed by different whole cells
with high concentrations of GlcNAc. The Neu5Ac concentration in
reaction solutions with an E. coli K12 /pBVN and E. coli K12 /pBVS cells
mixture(&),E.coliK12/pBVNsScells($),orE.coliDT26/pBVNsScells
(m) as the catalysts. The initial pyruvate concentration is 500 mM. The
performance was analyzed at 0, 12, 24, 36, 48 and 60 h.
www.nature.com/scientificreports
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investigated to further understand the reasons leading to the above
advantages. The apparent kinetic parameters were determined using
Lineweaver-Burk plots as described in the method (Fig S1)
29,30. The
Km’ values of reactions catalyzed by E. coli K12/pBVNsS, E. coli
DT26/pBVNsS and E. coli DT26/pBVNsS supplemented with
CTAB were 2.2, 3.3 and 4.5 times lower than that with the coupled
cells, while the Vmax’ values were increased by 1.7, 1.2 and 2.3 times,
respectively (Table 4). These results imply that a higher Neu5Ac
production rate can be achieved using lower concentrations of sub-
strates by packaging Neu5Ac aldolase and GlcNAc 2-epimerase in
one cell, disrupting nagE and supplying the surfactant, which may
weaken mass transfer resistance and eliminate side reactions. When
we calculate the overall reaction efficiency, Vmax’/Km’, the reaction
with E. coli DT26/pBVNsS (supplemented with CTAB) exhibited
significantly enhanced bioconversion efficiency, with a 10-fold
increase compared to the method using coupled cells.
Discussion
Use of whole-cell biocatalysts for the industrial synthesis of chemi-
cals has been attracting much attention as an environment-friendly
syntheticmethod
19.However,therearestillsomeproblemsshouldbe
taken into consideration (i.e. permeation of substrates across the cell
membrane, side reactions causing degradation of products, accu-
mulation of byproducts, etc.), which hinder the industrialization of
whole-cellbiocatalysis
19.Neu5Acisanimportantprecursorofthera-
peuticchemicals,whichcanbeproducedbywhole-cellbiocatalysis
25.
The two problems about substrate permeation and side reactions
have seriously impeded the application of whole-cell biocatalysis in
Neu5Ac production
25. Therefore, the development of method to
solve the problems is very important. Here, the permeation resist-
ance was reduced by coexpressing slr1975 and nanA, which should
avoid the transfer of the intermediate ManNAc. The nagE gene
of E. coli K12 encoding the GlcNAc-specific PTS transporter
(EIICBA
Nag) was also successfully knocked out to create the strain
E. coli DT26 whose PTS mediated metabolism of GlcNAc was
blocked (Fig. 2CD, Fig. S2). The strain should be advantageous as
a host strain for Neu5Ac production from GlcNAc for the less side
reactions about GlcNAc. Since Neu5Ac is a drug precursor, we also
put safety as a key consideration. It was reported that the use of
temperature induced expression vector was safe comparing with
chemical-induced systems
31. Induction by temperature shift is also
superior to that by chemical stimulation when the biocatalytic pro-
duction of therapeutic products is scaled-up, because the former is
cheaper and easier to operate
28. E. coli K12 is a nonpathogenic strain
whose genetic background has been studied extensively, and its
genome has been sequenced
32,33. Many methods to removing the
endotoxin,whichcancausepyrogenicandendotoxicshockreactions
in mammals, were also developed
34. Therefore the temperature
induced vector pBV220 and E. coli K12 were used in this work.
As we expect, strain E. coli DT26/pBVNsS (reaction A) showed
significant advantages compared to coupled cells (reaction C) and
E.coli K12/pBVNsS (reaction B). Inreaction B, anincrease (ofabout
46.8%) in Neu5Ac amount compared to reaction C (Table 3 and
Fig. 1). Both the Neu5Ac amount and Neu5Ac yield were greatly
increased in reaction A compared to reaction B (about 1.5 fold;
Table 3). The average rates of reactions B and A were 1.0 and
1.4 mmol l
21 h
21, respectively, during the phase in which the yield
increased (Table 3). It is reported that productivity of whole-cell
biocatalysis is often severely compromised by cell membrane, and
can be significantly enhanced by treating the cell membrane
35.
Therefore, it is logical to suggest that the elimination of membrane
penetration by the intermediate might have accelerated the mass
transfer and contributed to the increase of Neu5Ac amount. In addi-
tion,thenagE knockout destroyedthe EIICBA
Nagsothatthe amount
of GlcNAc being phosphorylated and then consumed by the cells
decreased. Thus, the amount of GlcNAc transported without phos-
phorylation, which serves as the substrate for GlcNAc 2-epimerase,
increased. The relatively high substrate concentration should
result in higher reaction rates and final amounts of Neu5Ac. The
apparently improved Neu5Ac yield in the reaction A, where E. coli
DT26/pBVNsS is used, might be due to the reduced consumption of
GlcNAc.
We have previously reported that Neu5Ac production is likely
biphasic by coupled cells (reaction C), with an early rapid rate and
a later slower rate
24. Here, we did not observe the phenomenon in
reaction A or B. We initially speculated that this phenomenon was
caused bycelllysis, andperformed experiments (analyzed the super-
natant obtained by centrifuging reaction mixture) to demonstrate
this. However, the result showed that there was no obvious protein
release which should be caused by cell lysis. As a phenomenon that
existed in Neu5Ac production using coupled cells, it is logical to
propose that this is related to the mass transfer of the intermediate
ManNAc, and the elimination of mass transfer resistance of the
intermediate ManNAc have led to the elimination of the later phase
of slower rate.
It is considered that the use of a high concentration of pyruvate to
drive Neu5Ac production is not ideal, because it is difficult to isolate
Neu5Ac from reaction mixtures containing high concentrations of
pyruvate
10,11.ByeliminatingthesidereactionsrelatedtoGlcNAc,itis
expected that the substrate GlcNAc, which can be separated from
Neu5Ac by a simple operation
10,36, could be used to drive Neu5Ac
production. In addition, compared with pyruvate, the high GlcNAc
concentration did not seriously inhibit the enzyme activities
(Fig.S3).Therefore,1 MGlcNAcwasusedinthefollowingreactions.
As expected, the reaction with a high GlcNAc concentration and
E. coli DT26/pBVNsS as the catalyst showed a higher yield and a
higher Neu5Ac amount than other two reactions (Fig. 4). The initial
pyruvate concentration was also optimized based on the molar ratio
of Neu5Ac to pyruvate when the reaction reached equilibrium for
subsequent product isolation. Based on the result, 500 mM pyruvate
was selected as the optimal concentration (Fig. S4).
Forsmallhydrophilicmolecules(molecularmass,600 Da),such
as pyruvate and GlcNAc, the inner membrane of the cell is the
primary barrier to mass transfer
35. It was reported that permeabiliz-
ing the membrane using certain compounds such as surfactants and
organic solvents could enhance the Neu5Ac producing rate
21,23. The
Figure 5 | Time courses of Neu5Ac production by E. coli DT26/pBVNsS
with and without CTAB. $, Neu5Ac (without CTAB); &, Neu5Ac
(with 0.03% CTAB). Error bars indicate s.d. (n53).
www.nature.com/scientificreports
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concentration(CMC)canenhancethepermeabilityofthecellmem-
brane without destroying it
35,37. After investigating the effects of dif-
ferent surfactants at different concentrations, 0.03% CTAB was used
for whole-cell catalysis (Fig. S5). In comparison with the reaction
without CTAB, the Neu5Ac amount and reaction rate increased by
154.7%(from 75 6 3.8 mM to 191 6 10.5 mM) and 1.5 times (from
2.1 mM h
21 to 5.3 mM h
21), respectively (Fig. 5). This result shows
thateliminationofmasstransfer canefficientlyenhance theNeu5Ac
production, andindicates that the masstransfer resistance caused by
cell membrane is indeed a major obstacle of whole-cell biocatalytic
Neu5Ac production.
It is notable that the effect of CTAB is similar to that caused by
packagingthetwoenzymesinasinglecell.AsshowninTable4,both
the methods can reduce the Km’ and increase the Vmax’, which sug-
gest that similar factors were involved in them. It was reported that
the apparent Km values of immobilized enzymes increased in most
cases for the immobilizations increased the diffusion limitations
38.
Therefore, it is logical to suggest that reduction of diffusion limita-
tions would reduce the apparent Km of enzymes. It wasalso reported
that addition of surfactant can reduce the diffusion limitations
caused by membrane
35. Moreover, the penetration of ManNAc can
be avoided by packaging the two enzymes in a single cell. It is not
difficult to conclude that boththe methods enhanced the reaction by
improving the mass transfer.
In summary, a powerful engineered whole-cell catalyst (E. coli
DT26/pBVNsS) was constructed in which Neu5Ac aldolase and
GlcNAc 2-epimerase were coexpressed from a temperature-induced
expressionvectorinaGlcNAc-specificPTSeliminatedsystem.Using
this catalyst, we developed an efficient process for the one-pot
synthesis of Neu5Ac. The side reactions and mass transfer limita-
tions due to the membrane barrier were greatly reduced in this pro-
cess.In comparisonwith whole-cell catalysisusing coupled cells, our
processresultedinamuchhigherNeu5Acamount(191610.5 mM,
59.0 6 3.2 g l
21) and a greatly enhanced bioconversion efficiency
(10 times greater than coupled cells). Since the expensive activator
ATP, which is necessary in the free enzyme process, could be omit-
ted, our process is highly attractive in terms of convenience, effi-
ciency, and economy. Moreover, as mass transfer resistance caused
bymembraneisaubiquitousreasonwhichleadstolowreactionrates
ofwholecellcatalyses
35,itis reasonabletosuggestthat ourmethodis
also useful in other similar biocatalyses, especially that referring
multiple-step reactions.
Methods
Bacterial strains, plasmids and culture conditions. All the bacterial strains and
plasmids used are listed in Table 1. E. coli DH5a was used as host in general genetic
manipulation. E. coli K12 from American Type Culture Collection (ATCC 25404)
was used as the host strain for constructed recombinant plasmids. Synechocystis sp.
PCC6803wasusedasthesourceofgeneslr1975,whichencodesGlcNAc2-epimerase.
The gene encoding Neu5Ac aldolase was from plasmid pET15b-nanA
23. Plasmid
pBV220wasused inconstructionof recombinant plasmids
24.Allthe genes used were
initially cloned into pMD18-T (Takara Co., Ltd., Dalian, China) for sequencing.
Plasmids pLOI2065, pKD46, and pFT-A were used in gene disruption
39. LB medium
(tryptone1%,yeastextract0.5%,NaCl1%,pH7.5)wasusedforgrowingE.colicells
40
where ampicillin (0.1 g l
21) was added when necessary. E. coli strains were grown at
37uC if not indicated.
Genetic methods. Standard methods were used for restriction digestions,agarose gel
electrophoresis, and isolation of plasmid and genomic DNA
40,41. Primers listed in
Table 2 were used to amplify corresponding genes. Chromosomal integration of
mutated genes was facilitated by pKD46 containing an arabinose-inducible Red
recombinase
42. Integrants were selected by using antibiotic resistance, screened for
Table 1 | Bacterial strains and plasmids.
Strain or plasmid Description Source or reference
E. coli strain
DH5a F
2 W80 lacZDM15D(lacZYA-argF) U169 deoR recA1 endA1 hsdR17 (rK
2 mK
1)
gal-phoA supE44 l
2 thi-1 gyrA96 relA1
Collection in our lab
K12 wild type ATCC 25404
DT12 K12, DnagE::FRT-tet-FRT This study
DT26 K12, DnagE::FRT This study
K12/pBVN pBV220 harboring nanA
24
K12/PBVS pBV220 harboring slr1975
24
Synechocystis sp. PCC6803 FACHB-898 (Wuhan, China)
Plasmid
pET15b-nanA pET15b harboring nanA (Neu5Ac aldolase; Amp
r)
23
pMD18-T bla TA cloning vector (Amp
r) TaKaRa
pMD18-T4639 pMD18-T harboring nagE (Amp
r) This study
pMD18-T4740 pMD18-T harboring nagE::FRT-tet-FRT (Amp
r) This study
pBV220 bla, pUC8 origin, cI857
ts,P RPL promoter (Amp
r) Collection in our lab
pBVNsS pBV220 harboring slr1975-SD-nanA (GlcNAc 2-epimerase; Neu5Ac aldolase; Amp
r) This study
pLOI2065 bla, FRT-tet-FRT, colE1 (Amp
r)
39
pKD46 bla, l, b, exo, pSC101 replicon
ts (red recombinase; Amp
r)
39
pFT-A bla, flp, pSC101 replicon
ts (FLP recombinase; Amp
r)
39
Table 2 | Primers.
Name Sequence Restriction site and other element
a
RecA 59-ggCgAATTCATggCAACgAATTTACgTggC-39 EcoRI
RecB 59-TTATCTCCCTCgAgTATTCACCCgCgCTCTTgCA-39 XhoI,SD
RecC 59-ATACTCgAgggAgATAAATgATTgCCCATCgCCgT-39 XhoI
RecD 59-ggCgTCgACTTAACTAACCggAAgTTggAgA-39 SalI
PnagE-u 59-ATgAATATTTTAggTTTTTTCC-39
PnagE-d 59-TTACTTTTTgATTTCATACAgC-39
Ptet-u 59-gggTACCgAgCTCgAATT-39
Ptet-d 59-ggggAgCTTgTCgACAAT-39
aSD, Shine-Dalgarno sequence.
www.nature.com/scientificreports
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analyses of PCR products and fermentation profiles. FRT (FLP recognition target)-
flanked antibiotic resistance genes were deleted by using FLP recombinase
39,42.
Construction of pBVNsS. Recombinant PCR
43 was performed using primers RecA,
RecB,RecC,andRecD.Inthefirstround,thegenenanA(fragmentAB)wasamplified
by PCR with primers RecA and RecB at an annealing temperature of 60uC using
pET15b-nanA as the template. Similarly, the gene slr1975 (fragment CD) was
obtained using primers RecC and RecD and pBVS as the template. After purification
bygelextraction,amixtureoffragmentsABandCDwasusedasthetemplatesforthe
second round of PCR with primers RecA and RecD to obtain fragment AD (DNA
fragment contain both nanA and slr1975). Both AD and pBV220 were digested with
therestrictionenzymesEcoRIandSalI.LigationoftheADandpBV220resultedinthe
co-expression plasmid pBVNsS (Fig. 2A, Fig. S1).
DisruptionofnagE. ThenagEgene ofE.coli K12encodingthe GlcNAc-specific PTS
transporter(EIICBA
Nag)wasknockedouttoeliminateGlcNAcmetabolismbyusinga
method described by Causey et al.
39. A single derivative of pMD18-T was selected in
whichtheamplifiednagEgenewasorientedinthesamedirectionasthelacpromoter
(pMD18-T-4639). The fragment between two Aor51HI sites of nagE was replaced by
the SmaI fragment from pLOI2065 containing a tet gene flanked by FRT sites to
produce pMD18-T-4740. Plasmid pMD18-T-4740 served as a template for the
amplification of nagE::FRT-tet-FRT (3.4 kbp) with primers PnagE-u and PnagE-d.
Amplified DNA was integrated into E. coli K12/pKD46 as described
39 to produce
DT12. The tet gene was removed by using FLP recombinase, and the resulting strain
was designated DT26 (Fig. 2C, Fig. S2).
Whole-cell catalyst preparation. One percent inoculum of the overnight culture of
E. coli strain K12 containing plasmid pBVNsS, pBVN, or pBVS was inoculated in LB
medium (containing 100 mg l
21 ampicillin), and incubated at 30uC with shaking for
2 h. The temperature was then increased to 42uC to induce the cells, and incubation
was continued for 5 h with shaking. The cells were collected by centrifugation at
8,000 rpm for 5 min and then washed twice with 0.85% NaCl solution.
Whole-cell reactions. Erlenmeyer flasks (50 mL) were used in all the reactions in
which Neu5Ac was produced. The reaction mixture (8 mL) contained 60 mM pot-
assium phosphate buffer (PKB, pH 7.4), 10 mM MgCl2. It was incubated in a rotary
shaker at 200 rpm and 30uC. Appropriate concentrations (below the critical micelle
concentrations) of surfactants (Triton X-100, CHAPS, CTAB, and SDS) were added
whennecessary.Neu5Ac,ManNAc,GlcNAc,andpyruvatewereanalyzedasreported
earlier
23.
Kinetics for different types of biocatalytic reactions. Whole-cell biocatalytic reac-
tions were performed with various substrate (GlcNAc) concentrations (100 mM,
200 mM, 300 mM, 400 mM, and 500 mM) in order to compare reaction kinetics for
the three types of reaction systems (reaction with coupled cells as catalyst, reaction
with E. coli K12/pBVNsS as catalyst, and reaction with E. coli DT26/pBVNsS as
catalyst and containing 0.03% CTAB). In all the reactions, pyruvate concentration
was 1 M, and the reaction rates were determined by calculating the Neu5Ac pro-
ducing rate. Since all the reactions showed Michael-Menten kinetic patterns,
Lineweaver-Burk plot analysis was performed for determining the apparent kinetic
parameters(Km’,Vmax’,andVmax’/Km’)whichwereanalogoustothose(Km,Vmax,and
Vmax/Km) for enzymatic reactions.
Analytical methods. The activities of Neu5Ac aldolase and GlcNAc 2-epimerase
were assayed according to previous reports
12,21. One unit of enzyme activity of
Neu5Ac aldolase was defined as the amount that produces 1 mmol of pyruvate per
minuteat37uC.OneunitofenzymaticactivityofGlcNAc2-epimerasewasdefinedas
theamountthatproduces1 mmolofManNAcperminat32uC.TheBradfordprotein
assay was used to determine the amount of total protein
44. The concentrations of
Neu5Ac, ManNAc, GlcNAc, pyruvate, and all the carbon sources were measured by
high-performance liquid chromatography (HPLC, Agilent 1100 series, Hewlett–
Packard), equipped with a Bio-Rad Aminex HPX-87H column (30037.8 mm) and a
refractive index detector. Analysis was performed with a mobile phase of 10 mM
H2SO4 at a flow rate of 0.4 ml min
21 and at 55uC.
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